Abstract
We develop a minimal compartmental model to analyze policies on mobility restriction in Italy during the Covid-19 outbreak. Our findings show that a premature lockdown barely shifts the epidemic in time: moreover, beyond a critical value of the lockdown strength, an epidemic that seems to be quelled fully recovers after lifting the restrictions. We investigate the effects on lockdown scenarios and exit strategies by introducing heterogeneities in the model. In particular, we consider Italian regions as separate administrative entities in which social interactions through different age classes occur. We find that, due to the sparsity of the mobility matrix, epidemics develop independently in different regions once the outbreak starts. Moreover, after the epidemics ha started, the influence of contacts with other regions becomes soon irrelevant. Sparsity might be responsible for the observed delays among different regions. Analogous arguments apply to the world/countries scenario. We also find that disregarding the structure of social contacts could lead to severe underestimation of the post-lockdown effects. Nevertheless, age class based strategies can help to mitigate rebound effects with milder strategies. Finally, we point out that these results can be generalized beyond this particular model by providing a description of the effects of key parameters on non-medical epidemic mitigation strategies.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
A.S., E.B., M.C. and W.Q. acknowledge the support from CNR P0000326 project AMOFI (Analysis and Models OF social medIa) and CNR-PNR National Project DFM.AD004.027 Crisis-Lab.
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
all the data used are freely available from online repositories or downloadable research papers
